Patent: 6,316,408
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,316,408
| Title: | Methods of use for osetoprotegerin binding protein receptors |
| Abstract: | A novel polypeptide, osteoprotegerin binding protein, involved in osteolcast maturation has been identified based upon its affinity for osteoprotegerin. Nucleic acid sequences encoding the polypeptide, or a fragment, analog or derivative thereof, vectors and host cells for production, methods of preparing osteoprotegerin binding protein, and binding assays are also described. Compositions and methods for the treatment of bone diseases such as osteoporosis, bone loss due to arthritis or metastasis, hypercalcemia, and Paget\'s disease are also provided. Receptors for osteoprotegerin binding proteins are also described. The receptors, and agonists and antagonists thereof, may be used to treat bone diseases. |
| Inventor(s): | Boyle; William J. (Moorpark, CA) |
| Assignee: | Amgen Inc. (Thousand Oaks, CA) |
| Application Number: | 09/052,521 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,316,408
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2017-04-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
